• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Model Number BXA077902A
Device Problem Fracture (1260)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/12/2020
Event Type  malfunction  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.Review of device manufactory record history confirmed device met pre-release specifications.The endoprosthesis was deployed and remains in patient.The delivery catheter was returned and results are pending on completion of investigation.
 
Event Description
During a complex thoracoabdominal aneurysm procedure, a 7fr cook sheath was used to advance a gore® viabahn® vbx balloon expandable endoprosthesis (vbx device) to the superior mesenteric artery.As reported, the patient has a very tortuous anatomy.The vbx device was placed and deployed at the intended treatment site with no issues.However, upon withdrawal of the delivery catheter over the.035 rosen wire the proximal part of the vbx catheter just below the hub tore apart from the rest of the catheter.The entire sheath with the broken vbx delivery catheter inside, was withdrawn from the patient as one unit.The sheath was then replaced with an 8fr terumo sheath and a new device was placed.The procedure ended with good results.The patient did not experience any adverse consequences.
 
Manufacturer Narrative
Patient age and weight were requested but not made available.Code 213: engineering evaluation: the returned specimen was identified to be a 7 x 79 x 1350 mm configuration, which matches the event description.The gore® viabahn® vbx balloon expandable delivery system was returned with the hub detached and the catheter stuck within a non-gore introducer sheath.Because the sheath is not a gore product it was not evaluated.The delivery catheter displayed two kinks as well as a 7cm section of necking beginning at the separation point.The delivery catheter lot met specifications for tensile strength.The catheter of the vbx delivery system is 100% inspected at the end of the manufacturing process for any mechanical damage, including necking.Any devices with mechanical damage are rejected.The device history file did not indicate any anomalies occurred that would increase the force to withdraw the device.Based on the device evaluation performed, no manufacturing anomalies were identified to which the event could be definitively attributed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10804578
MDR Text Key217672996
Report Number2017233-2020-01423
Device Sequence Number1
Product Code PRL
UDI-Device Identifier00733132637539
UDI-Public00733132637539
Combination Product (y/n)Y
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 02/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/18/2022
Device Model NumberBXA077902A
Device Catalogue NumberBXA077902A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/03/2020
Initial Date Manufacturer Received 10/12/2020
Initial Date FDA Received11/06/2020
Supplement Dates Manufacturer Received10/12/2020
Supplement Dates FDA Received02/15/2021
Patient Sequence Number1
-
-